SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

Cipla, ITC and ICICI Bank to see some action today

Cipla Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 500087 | NSE: CIPLA

20 Dec 2021 Evaluate

Cipla has received approval from the US Food and Drug Administration (USFDA) to market the Lanreotide injection in the American market. The Lanreotide injection is used for the treatment of acromegaly and gastroenteropancreatic neuroendocrine tumors (GEP-NETs). This approval is a significant step for its US business and is in line with its aspiration to continue growth in its complex product pipeline and address unmet patient needs.

ITC has bought 8.70 per cent equity stake in Mother Sparsh Baby Care, a D2C Ayurvedic and natural personal care brand. The company has acquired on December 17, 2021, in the first tranche, 100 equity shares of Rs 10 each and 940 Compulsorily Convertible Preference Shares of Rs 10 each of Mother Sparsh Baby Care, representing 8.70 per cent of its share capital on a fully diluted basis. Mother Sparsh is a premium Ayurvedic and natural personal care start-up in the D2C space, focusing on mother and baby care segment.

ICICI Bank has raised Rs 5,000 crore through senior unsecured redeemable long-term bonds in the nature of debentures and allotted 50,000 bonds on private placement basis, date of allotment being December 17, 2021. The bonds are redeemable at the end of 10 years (redemption date being December 17, 2031). There are no special rights/ privileges attached to the bonds.

Zomato has completed the acquisition of 1,53,914 compulsorily convertible preference shares and 9,824 equity shares collectively aggregating to 7.89% of the share capital in Bigfoot Retail Solution (Shiprocket), for an aggregate cash consideration of Rs 557.17 crore.

UltraTech Cement has commenced operations from its bulk terminal at Kalamboli, Navi Mumbai. This is the 7th bulk terminal of the Company. The earlier 6 are located at Cochin in Kerala; Mangalore and Doddaballapur in Karnataka; Uran and Pune in Maharashtra and Shankarpalli in Telangana.

Ircon International (IRCON) has entered into Share Subscription and Shareholders' Agreement with Ayana Renewable Power (Ayana) for the execution of the project of setting-up 500 MW solar power plant through Joint Venture (JV) Company which will be incorporated by IRCON and Ayana.

Aditya Ispat has received the necessary Consent for Operation (CFO) from the Telangana State Pollution Control Board, Telangana for commencing the operations of UNIT-II at Kamaram Village, Shankarampet (R) Mandal at Medak District, State Telangana for producing steel wire products and fasteners. The approximate production capacity of the Unit-II will be 3000 tons per anum. The company is expected to commence the trial production in Unit-II within this month of December, 2021.

Cipla Share Price

1232.90 4.00 (0.33%)

21-Apr-2026 16:59 View Price Chart

Peers

Company Name	CMP
Sun Pharma Inds.	1665.25
Dr. Reddys Lab	1220.75
Cipla	1232.90
Zydus Lifesciences	928.85
Lupin	2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

PROPRIETARY FRAMEWORK

Portfolio
Architecture >
Stock Picking.

Stop managing a collection of "tips." Access the ABC Framework to build a portfolio that survives cycles and compounds wealth.

Core for Stability

Booster for Alpha

Amplifier for Exponential Wealth

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Access Sapphire ABC Strategy →

Limited Capacity for New Fiduciary Partners

Cipla, ITC and ICICI Bank to see some action today

MoneyWorks4Me Premium

Follow us at

MoneyWorks4Me

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.